Monopharm-C: To begin Phase I U.S. trial

Hygeia Pharmaceuticals Inc., subsidiary of Hygeia Holdings Inc. (VSE:HYG) Product: Monopharm-C, human IgM antibody Indication: Colorectal and pancreatic carcinomas, and adenocarcinomas of the lung Sta...